<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication" xmlns:n2016="http://publications.europa.eu/resource/schema/ted/2016/nuts" xsi:schemaLocation="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication TED_EXPORT.xsd" VERSION="R2.0.9.S03.E01" DOC_ID="295433-2020" EDITION="2020121"><TECHNICAL_SECTION><RECEPTION_ID>20-304430-001</RECEPTION_ID><DELETION_DATE>20200930</DELETION_DATE><FORM_LG_LIST>FR </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>121</NO_OJ><DATE_PUB>20200625</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2020/S 121-295433</NO_DOC_OJS><URI_LIST><URI_DOC LG="FR">http://ted.europa.eu/udl?uri=TED:NOTICE:295433-2020:TEXT:FR:HTML</URI_DOC></URI_LIST><LG_ORIG>FR</LG_ORIG><ISO_COUNTRY VALUE="FR"/><IA_URL_GENERAL>http://www.ch-cahors.fr/etablissement/marches-publics</IA_URL_GENERAL><ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV><ORIGINAL_CPV CODE="33650000">General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</ORIGINAL_CPV><ORIGINAL_CPV CODE="33690000">Various medicinal products</ORIGINAL_CPV><ORIGINAL_CPV CODE="33640000">Medicinal products for the genitourinary system and hormones</ORIGINAL_CPV><ORIGINAL_CPV CODE="33630000">Medicinal products for dermatology and the musculo-skeletal system</ORIGINAL_CPV><ORIGINAL_CPV CODE="33660000">Medicinal products for the nervous system and sensory organs</ORIGINAL_CPV><ORIGINAL_CPV CODE="33620000">Medicinal products for the blood, blood-forming organs and the cardiovascular system</ORIGINAL_CPV><ORIGINAL_CPV CODE="33670000">Medicinal products for the respiratory system</ORIGINAL_CPV><ORIGINAL_CPV CODE="33610000">Medicinal products for the alimentary tract and metabolism</ORIGINAL_CPV><n2016:PERFORMANCE_NUTS CODE="FRJ">LANGUEDOC-ROUSSILLON-MIDI-PYRÉNÉES</n2016:PERFORMANCE_NUTS><n2016:CA_CE_NUTS CODE="FRJ25">Lot</n2016:CA_CE_NUTS><n2016:CA_CE_NUTS CODE="FRJ">LANGUEDOC-ROUSSILLON-MIDI-PYRÉNÉES</n2016:CA_CE_NUTS><n2016:TENDERER_NUTS CODE="FRK2">Rhône-Alpes</n2016:TENDERER_NUTS><n2016:TENDERER_NUTS CODE="FRF12">Haut-Rhin</n2016:TENDERER_NUTS><n2016:TENDERER_NUTS CODE="FR101">Paris</n2016:TENDERER_NUTS><n2016:TENDERER_NUTS CODE="FRK26">Rhône</n2016:TENDERER_NUTS><n2016:TENDERER_NUTS CODE="FRK1">Auvergne</n2016:TENDERER_NUTS><n2016:TENDERER_NUTS CODE="FR107">Val-de-Marne</n2016:TENDERER_NUTS><n2016:TENDERER_NUTS CODE="FRJ27">Tarn</n2016:TENDERER_NUTS><n2016:TENDERER_NUTS CODE="FRF23">Marne</n2016:TENDERER_NUTS><n2016:TENDERER_NUTS CODE="FRL04">Bouches-du-Rhône</n2016:TENDERER_NUTS><VALUES><VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">200000000</VALUE></VALUES><REF_NOTICE><NO_DOC_OJS>2020/S 015-030356</NO_DOC_OJS></REF_NOTICE></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20200622</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="1">Open procedure</PR_PROC><RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01B03</HEADING><INITIATOR>01</INITIATOR></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Фpaнция</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Фармацевтични продукти</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Francie</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Léčivé přípravky a zdravotnické prostředky</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Frankrig</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Lægemidler</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Frankreich</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Arzneimittel</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Γαλλία</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Φαρμακευτικά προϊόντα</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>France</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Pharmaceutical products</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>Francia</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Productos farmacéuticos</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Prantsusmaa</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Ravimid</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Ranska</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Farmaseuttiset tuotteet</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>France</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Produits pharmaceutiques</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Fhrainc, an</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Pharmaceutical products</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Francuska</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Farmaceutski proizvodi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Franciaország</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Gyógyszerészeti termékek</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Francia</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Prodotti farmaceutici</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Prancūzija</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Farmacijos produktai</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Francija</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Farmācijas izstrādājumi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>Franza</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Prodotti farmaċewtiċi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Frankrijk</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Farmaceutische producten</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Francja</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Produkty farmaceutyczne</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>França</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Produtos farmacêuticos</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Franţa</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Produse farmaceutice</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Francúzsko</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Farmaceutické výrobky</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Francija</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Farmacevtski proizvodi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Frankrike</TI_CY><TI_TOWN>Cahors</TI_TOWN><TI_TEXT><P>Läkemedel</P></TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="FR">Centre hospitalier de Cahors</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="FR"><LEGAL_BASIS VALUE="32014L0024"/><CONTRACTING_BODY><ADDRESS_CONTRACTING_BODY><OFFICIALNAME>Centre hospitalier de Cahors</OFFICIALNAME><ADDRESS>52, place Bergon — BP 50269</ADDRESS><TOWN>Cahors</TOWN><POSTAL_CODE>46005</POSTAL_CODE><COUNTRY VALUE="FR"/><CONTACT_POINT>à l'attention de M. le directeur, mandataire du GCS achats en santé Occitanie-GCS ASO</CONTACT_POINT><PHONE>+33 565208478</PHONE><E_MAIL>achats.pds@ch-cahors.fr</E_MAIL><FAX>+33 565205096</FAX><n2016:NUTS CODE="FRJ25"/><URL_GENERAL>http://www.ch-cahors.fr/etablissement/marches-publics</URL_GENERAL><URL_BUYER>http://www.achatpublic.com</URL_BUYER></ADDRESS_CONTRACTING_BODY><ADDRESS_CONTRACTING_BODY_ADDITIONAL><OFFICIALNAME>Centre hospitalier de Cahors, pour le compte des structures bénéficiaires du GCS ASO</OFFICIALNAME><TOWN>Cahors Cedex</TOWN><POSTAL_CODE>46005</POSTAL_CODE><COUNTRY VALUE="FR"/><CONTACT_POINT>Pharmacie, à l'attention de M. Loïc Rolland</CONTACT_POINT><PHONE>+33 565208478</PHONE><E_MAIL>achats.pds@ch-cahors.fr</E_MAIL><FAX>+33 565205096</FAX><n2016:NUTS CODE="FRJ"/><URL_GENERAL>http://www.ch-cahors.fr/etablissement/marches-publics</URL_GENERAL><URL_BUYER>http://www.achatpublic.com</URL_BUYER></ADDRESS_CONTRACTING_BODY_ADDITIONAL><JOINT_PROCUREMENT_INVOLVED/><CA_TYPE_OTHER>Établissement public de santé</CA_TYPE_OTHER><CA_ACTIVITY VALUE="HEALTH"/></CONTRACTING_BODY><OBJECT_CONTRACT><TITLE><P>Produits de santé: fourniture de médicaments pour les années 2020 à 2024 (45 mois)</P></TITLE><REFERENCE_NUMBER>AO 2020 GCS Achats en Santé d'Occitanie</REFERENCE_NUMBER><CPV_MAIN><CPV_CODE CODE="33600000"/></CPV_MAIN><TYPE_CONTRACT CTYPE="SUPPLIES"/><SHORT_DESCR><P>— tous les autres candidats retenus sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics,</P><P>— accord-cadre alloti de 771 lots (1 à 771) de fourniture de médicaments à compter du 1.7.2020 pour trois ans et neuf mois (45 mois): médicaments (avec ou sans AMM, voire de dispositifs médicaux) concernant: anti-infectieux et anti-parasitaires, anti-néoplasiques et immuno-modulateurs, autorisation temporaire d'utilisation, divers (notamment antidotes, produits de contraste) et produits radio-pharmaceutiques à usage diagnostique, hormones systémiques, médicaments dermatologiques, muscle et squelette, organes sensoriels, sang et organes hématopoïétiques, système cardiovasculaire, système génito-urinaire et hormones sexuelles, système nerveux, système respiratoire et voies digestives et métabolisme.</P></SHORT_DESCR><VAL_TOTAL CURRENCY="EUR">200000000</VAL_TOTAL><LOT_DIVISION/><OBJECT_DESCR ITEM="1"><TITLE><P>Anti-infectieux et anti-parasitaires</P></TITLE><LOT_NO>00J</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33650000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— anti-infectieux et anti-parasitaires du lot 1 à 116.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="2"><TITLE><P>Anti-néoplasiques et immuno-modulateurs</P></TITLE><LOT_NO>00L</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33650000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— anti-néoplasiques et immuno-modulateurs du lot 117 à 175.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="3"><TITLE><P>Autorisation temporaire d'utilisation</P></TITLE><LOT_NO>00ATU</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33690000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— autorisation temporaire d'utilisation du lot 176 à 196.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="4"><TITLE><P>Médicaments divers</P></TITLE><LOT_NO>00V</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33690000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— médicaments divers: antidotes, produits de contrastes et radio-</P><P>pharmaceutiques du lot 197 à 249.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="5"><TITLE><P>Hormones systémiques</P></TITLE><LOT_NO>00H</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33640000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— hormones systémiques (hormones sexuelles exclues) du lot 250 à 264.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="6"><TITLE><P>Médicaments dermatologiques</P></TITLE><LOT_NO>00D</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33630000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— médicaments dermatologiques du lot 265 à 305.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="7"><TITLE><P>Muscle et squelette</P></TITLE><LOT_NO>00M</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33630000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— muscle et squelette du lot 306 à 328.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="8"><TITLE><P>Organes sensoriels</P></TITLE><LOT_NO>00S</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33660000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— organes sensoriels du lot 329 à 353.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="9"><TITLE><P>Sang et organes hématopoïétiques</P></TITLE><LOT_NO>00B</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33620000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— sang et organes hématopoïétiques du lot 354 à 414.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="10"><TITLE><P>Système cardiovasculaire</P></TITLE><LOT_NO>00C</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33620000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— système cardiovasculaire du lot 415 à 487.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="11"><TITLE><P>Système génito-urinaire et hormones sexuelles</P></TITLE><LOT_NO>00G</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33640000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— système génito-urinaire et hormones sexuelles du lot 488 à 507.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="12"><TITLE><P>Système nerveux</P></TITLE><LOT_NO>00N</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33660000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— système nerveux du lot 508 à 657.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="13"><TITLE><P>Système respiratoire</P></TITLE><LOT_NO>00R</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33670000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— système respiratoire du lot 658 à 682.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="14"><TITLE><P>Voies digestives et métabolisme</P></TITLE><LOT_NO>00A</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33610000"/></CPV_ADDITIONAL><n2016:NUTS CODE="FRJ"/><SHORT_DESCR><P>— voies digestives et métabolisme du lot 683 à 771.</P></SHORT_DESCR><AC><AC_QUALITY><AC_CRITERION>Critères attribution RC</AC_CRITERION><AC_WEIGHTING>70</AC_WEIGHTING></AC_QUALITY><AC_PRICE><AC_WEIGHTING>30</AC_WEIGHTING></AC_PRICE></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR></OBJECT_CONTRACT><PROCEDURE><PT_OPEN/><CONTRACT_COVERED_GPA/><NOTICE_NUMBER_OJ>2020/S 015-030356</NOTICE_NUMBER_OJ></PROCEDURE><AWARD_CONTRACT ITEM="1"><LOT_NO>00J</LOT_NO><TITLE><P>Amikacine INJ</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Mylan médical</OFFICIALNAME><ADDRESS>Tous les candidats retenus lots 2 à 116, sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</ADDRESS><TOWN>Saint-Priest</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FRK2"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">184220</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="2"><LOT_NO>00L</LOT_NO><TITLE><P>Anti-neoplasiques et immunomodulateurs</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Arrow génériques</OFFICIALNAME><ADDRESS>Tous les candidats retenus lots 118 à 175, sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</ADDRESS><TOWN>Lyon</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FRK2"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">4510</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="3"><LOT_NO>00ATU</LOT_NO><TITLE><P>Acide ursodéoxycholique sol. Buv. oral</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Inresa, Tous les candidats retenus lots 177 à 196 sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</OFFICIALNAME><TOWN>Bartenheim</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FRF12"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">45136</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="4"><LOT_NO>00V</LOT_NO><TITLE><P>Charbon active flacon</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>SERB, Tous les candidats retenus lots 198 à 249 sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</OFFICIALNAME><TOWN>Paris</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FR101"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">21112</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="5"><LOT_NO>00H</LOT_NO><TITLE><P>Betamethasone 0,05 % sol. Buv. oral</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Arrow génériques, Tous les candidats retenus lots 251 à 264 sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</OFFICIALNAME><TOWN>Lyon</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FRK26"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">2423</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="6"><LOT_NO>00D</LOT_NO><TITLE><P>Acide fusidique 15 g crème</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Arrow génériques, tous les candidats retenus lots 266 à 305 sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</OFFICIALNAME><TOWN>Lyon</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FRK26"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">12651</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="7"><LOT_NO>00M</LOT_NO><TITLE><P>Acide pamidronique 90 mg INJ</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Pfizer, tous les candidats retenus lots 307 à 328 sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</OFFICIALNAME><TOWN>Paris</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FR101"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">26466</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="8"><LOT_NO>00S</LOT_NO><TITLE><P>Aciclovir ou ganciclovir ophtalmique</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Thea, tous les candidats retenus lots 330 à 353 sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</OFFICIALNAME><TOWN>Cournon</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FRK1"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">5016</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="9"><LOT_NO>00B</LOT_NO><TITLE><P>Acide acétylsalicylique cardiovasculaire oral</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Sanofi Aventis, tous les candidats retenus lots 355 à 414 sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</OFFICIALNAME><TOWN>Gentilly</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FR107"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">203923</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="10"><LOT_NO>00C</LOT_NO><TITLE><P>Adénosine 6 mg INJ</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Médac, tous les candidats retenus lots 416 à 487 sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</OFFICIALNAME><TOWN>Lyon</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FRK26"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">10389</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="11"><LOT_NO>00G</LOT_NO><TITLE><P>Adénome prostatique extraits végétaux</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Pierre Fabre médicament, tous les candidats retenus lots 489 à 507 sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</OFFICIALNAME><TOWN>Castres</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FRJ27"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">65324</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="12"><LOT_NO>00N</LOT_NO><TITLE><P>Acide acétylsalicylique oral</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Sanofi Aventis, tous les candidats retenus lots 509 à 657 sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</OFFICIALNAME><TOWN>Gentilly</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FR107"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">8734</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="13"><LOT_NO>00R</LOT_NO><TITLE><P>Anti-cholinergique en inhalation</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Boehringer Ingelheim, tous les candidats retenus lots 659 à 682 sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</OFFICIALNAME><TOWN>Reims</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FRF23"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">6789</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="14"><LOT_NO>00A</LOT_NO><TITLE><P>Acide aminosalicylique 5-asa et analogues oral</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-05-04</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>138</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>138</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Ferring, tous les candidats retenus lots 684 à 771 sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</OFFICIALNAME><TOWN>Marseille</TOWN><COUNTRY VALUE="FR"/><n2016:NUTS CODE="FRL04"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">4</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><COMPLEMENTARY_INFO><INFO_ADD><P>— tous les autres candidats retenus sont sur le site du CH de Cahors: http://www.ch-cahors.fr/etablissement/marches-publics</P></INFO_ADD><ADDRESS_REVIEW_BODY><OFFICIALNAME>Tribunal administratif de Montpellier</OFFICIALNAME><ADDRESS>6, rue Pitot</ADDRESS><TOWN>Montpellier Cedex 2</TOWN><POSTAL_CODE>34063</POSTAL_CODE><COUNTRY VALUE="FR"/><PHONE>+33 467548100</PHONE><E_MAIL>greffe.ta-montpellier@juradm.fr</E_MAIL><FAX>+33 467547410</FAX><URL>http://montpellier.tribunal-administratif.fr/</URL></ADDRESS_REVIEW_BODY><ADDRESS_MEDIATION_BODY><OFFICIALNAME>Tribunal administratif de Montpellier</OFFICIALNAME><ADDRESS>6, rue Pitot</ADDRESS><TOWN>Montpellier Cedex 2</TOWN><POSTAL_CODE>34063</POSTAL_CODE><COUNTRY VALUE="FR"/><PHONE>+33 467548100</PHONE><E_MAIL>greffe.ta-montpellier@juradm.fr</E_MAIL><FAX>+33 467547410</FAX><URL>http://montpellier.tribunal-administratif.fr/</URL></ADDRESS_MEDIATION_BODY><REVIEW_PROCEDURE><P>— référé pré-contractuel prévu aux articles L. 551-1 à L. 551-12 du Code de justice administrative (CJA), et pouvant être exercé avant la signature du contrat,</P><P>— référé contractuel prévu aux articles L. 551-13 à L. 551-23 du CJA, et pouvant être exercé dans les délais prévus à l'article R. 551-7 du CJA,</P><P>— recours pour excès de pouvoir contre une décision administrative prévu aux articles R. 421-1 à R. 421-7 du CJA, et pouvant être exercé dans les deux mois suivant la notification ou publication de la décision de l'organisme (le recours ne peut plus, toutefois, être exercé après la signature du contrat).</P></REVIEW_PROCEDURE><ADDRESS_REVIEW_INFO><OFFICIALNAME>Tribunal administratif de Montpellier</OFFICIALNAME><ADDRESS>6, rue Pitot</ADDRESS><TOWN>Montpellier Cedex 2</TOWN><POSTAL_CODE>34063</POSTAL_CODE><COUNTRY VALUE="FR"/><PHONE>+33 467548100</PHONE><E_MAIL>greffe.ta-montpellier@juradm.fr</E_MAIL><FAX>+33 467547410</FAX><URL>http://montpellier.tribunal-administratif.fr/</URL></ADDRESS_REVIEW_INFO><DATE_DISPATCH_NOTICE>2020-06-22</DATE_DISPATCH_NOTICE></COMPLEMENTARY_INFO></F03_2014></FORM_SECTION></TED_EXPORT>